Clinical Studies of Thrombopoietin
Author:
Basser Russell L.
Reference22 articles.
1. Kaushansky K Thrombopoietin: The primary regulator of platelet production. Blood 86: 419–31, 1995.
2. Vilmer E, Guglielmi P, David V, et al. Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation. J.Clin.Invest. 82: 755–61, 1988.
3. Basser RL, Rasko JEJ, Clarke K, et al. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 348: 1279–81, 1996.
4. O’Malley CJ, Rasko JEJ, Basser RL, et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 88: 3288–98, 1996.
5. Rasko JEJ, Basser RL, Boyd J, et al. Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Br J Haematol 97: 871–80, 1997.